Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 3/20 | 0.54 |
| ▸ | MAOB | P27338 | 2/20 | 0.53 |
| ▸ | AR | P10275 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.44 |
| ▸ | LTA4H | P09960 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | TTR | P02766 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3568078 | 0.85 | LTA4H (0.52) | CYP19A1MAOBARALDH1A1HPGD | |
| SCHEMBL6289952 | 0.84 | CYP19A1 (0.54) | CYP19A1MAOBARALDH1A1HPGD | |
| SCHEMBL16310207 | 0.84 | CYP19A1 (0.54) | CYP19A1MAOBARALDH1A1HPGD | |
| SCHEMBL6289949 | 0.84 | CYP19A1 (0.54) | CYP19A1MAOBARALDH1A1HPGD | |
| SCHEMBL9746014 | 0.83 | CYP19A1 (0.52) | CYP19A1MAOBARALDH1A1HPGD | |
| SCHEMBL9746473 | 0.83 | CYP19A1 (0.52) | CYP19A1MAOBARALDH1A1HPGD | |
| SCHEMBL5145150 | 0.83 | CYP19A1 (0.67) | CYP19A1MAOBARALDH1A1HPGD | |
| SCHEMBL1374021 | 0.83 | CYP19A1 (0.67) | CYP19A1MAOBARALDH1A1HPGD | |
| SCHEMBL31168160 | 0.83 | CYP19A1 (0.67) | CYP19A1MAOBARALDH1A1HPGD | |
| SCHEMBL3174815 | 0.83 | CYP11B1 (0.56) | CYP19A1MAOBPDE4BLTA4HCYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3521340-A1 | A PHTHALONITRILE MONOMER MODIFIED BY ORGANOPHOSPHATE FRAGMENTS, A METHOD FOR OBTAINING SAME, A BINDER BASED THEREON, AND A PREPREG | Joint Stock Company Scientific and Production Association "Unichimtek" (JSC PSA "Unichimtek) (RU) | 2019-08-07 | — | — | EP | disclosed |
| US-20190218235-A1 | Phthalonitrile Monomer Modified with Organophosphorus Fragments, a Method of Producing thereof, a Binder Based Thereon, and a Prepreg | JOINT STOCK COMPANY SCIENTIFIC AND PRODUCTION ASSOCIATION "UNICHIMTEK" (JSC PSA "UNICHIMTEK") (RU) | 2019-07-18 | — | — | US | disclosed |
| EP-3211023-A1 | PHTHALONITRILE MONOMER MODIFIED WITH ORGANOSILICON FRAGMENTS | Joint Stock Company Scientific and Production Association "Unichimtek" (JSC PSA "Unichimtek) (RU) | 2017-08-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190218235-A1 | Phthalonitrile Monomer Modified with Organophosphorus Fragments, a Method of Producing thereof, a Binder Based Thereon, and a Prepreg | THEM6, NOTUM, PNN | CYP19A1 1229/4885MAOB 1907/4885AR 2119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.